Clinical trials using patients own immune system has produced remissions in cancer patients with acute leukemia. Dr. Aaron Rapoport, the Gary Jobson professor in Medical Oncology of Medicine, and others, told ABC, "With this new gene transfer technology we are able to engineer a patients immune cells to attack their own cancer". This is being called a major break through. Log on to ABCnews.com and go to their health tab for complete information.